
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Are you Dr. Venneti?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sriram Venneti, MD is a board certified pathologist in Ann Arbor, Michigan. He is currently licensed to practice medicine in Michigan, Pennsylvania, and Pennsylvania.
Education & Training
- University of Pennsylvania Health SystemFellowship, Neuropathology, 2009 - 2011
- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2007 - 2009
- Bangalore Medical College
Certifications & Licensure
- MI State Medical License 2014 - 2027
- PA State Medical License 2007 - 2026
- PA State Medical License 2010 - 2026
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 3 citationsH3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas.Maria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, Ziwen Zhu, Brandon L McClellan
Biorxiv. 2025-02-05 - Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma.Nir Erez, Noa Furth, Vadim Fedyuk, Jack Wadden, Rayan Aittaleb
Cell Reports. Medicine. 2025-01-21 - 1 citationsTherapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma.Nneka E Mbah, Amy L Myers, Peter Sajjakulnukit, Chan Chung, Joyce K Thompson
Nature Communications. 2024-10-17
Press Mentions
- Medical School Faculty Promotions Approved by U-M Board of RegentsMay 22nd, 2024
- New Clues Toward Treating Paediatric Brain Tumours Harbouring Epigenetic MutationOctober 14th, 2021
- New Clues Toward Treating Pediatric Brain Tumors Harboring Epigenetic MutationOctober 13th, 2021
- Join now to see all
Grant Support
- Unravelling metabolic dependencies in H3K27M mutant DIPGUNIVERSITY OF MICHIGAN AT ANN ARBOR2019–2029
- Targeting metabolic dependencies in ZFTA-RELA fusion childhood ependymomasUNIVERSITY OF MICHIGAN AT ANN ARBOR2023–2028
- Targeting integrated metabolic and epigenetic pathways in childhood ependymomasUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027